Omar Boraie and Rutgers University

In order to improve the field of precision medicine at Rutgers University, the Omar Boraie Chair in Genomic Science was established.

According to Newswise, The the State University of New Jersey, also known as Rutgers University, know has a new academic chair. This was possible thanks to Omar Boraie, a prominent real estate developer from New Brunswick, New Jersey. He made a pledge, which consists of donating more than $1.5 million to the University’s 18 chair challenge campaign. The campaign was also possible thanks to a donation of more than $55 million on behalf of an anonymous individual. The Omar Boraie Chair in Genomic science will possibly bring better insights in the field of precision medicine.

Precision medicine, prominently through genomic science,, has been bringing fresh insights in the field of cancer research. It is unconventional and actually more precise in regards to how it deals with tumors, for example. By treating patients according to their unique genetics, oncologists can administer better individualized therapies instead. Genomic Science has been found to be helpful for those that have rare types of cancer. It has also helped people that have become immune to certain types of treatments. Rutgers Cancer Institute, which is part of Rutgers University, was one of the first medical facilities in the United States to implement genomic sequencing in cancer research, something unconventional.

Omar Boraie, a business magnate and financial expert, has also a rigorous background in the scientific field of chemistry. For many years, he has been interested in cancer research. And he hopes too that more people in the future will obtain the benefits of precision medicine. According to Robert S. DiPaola, the current director of Rutgers Cancer Institute, Boraie’s monetary donations will leave a legacy in the medical field.

Shridar Ganesan, who is considered to be one of the best oncologists in the world, will lead the Omar Boraie Chair in Genomic Science. Ganesan, who once did research for Harvard’s medical school, is also a director for transnational science and a professor of medicine for Rutgers University. The medical professional and scientist, other than being honored because of his nomination, thinks that there is still a lot to learn about cancer biology. But Genomic analysis has been proven to be incredibly helpful. Cancer is much more complicated than previously thought. Thus, because genomic analysis is superior in regards to understanding tumors, it must continuously be sought after by the medical community.


Leave a Reply

Your email address will not be published. Required fields are marked *